Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Andrey Tsedilin"'
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0286752 (2023)
Large peptide biosynthesis is a valuable alternative to conventional chemical synthesis. Enfuvirtide, the largest therapeutic peptide used in HIV infection treatment, was synthesized in our thermostable chaperone-based peptide biosynthesis system and
Externí odkaz:
https://doaj.org/article/ea127ecf10de49bfbdac0d0b9dec254d
Autor:
Murad Mollaev, Artur Zabolotskii, Neonila Gorokhovets, Elena Nikolskaya, Maria Sokol, Andrey Tsedilin, Mariia Mollaeva, Margarita Chirkina, Timofey Kuvaev, Anna Pshenichnikova, Nikita Yabbarov
Publikováno v:
Journal of Genetic Engineering and Biotechnology, Vol 19, Iss 1, Pp 1-10 (2021)
Abstract Background Difficult to express peptides are usually produced by co-expression with fusion partners. In this case, a significant mass part of the recombinant product falls on the subsequently removed fusion partner. On the other hand, multim
Externí odkaz:
https://doaj.org/article/2f34c10aeb634c0e8a8b9a05e8fb6d16
Publikováno v:
Biotechnology Reports, Vol 35, Iss , Pp e00734- (2022)
Synthetic peptides are in high demand as biologically active substances. Solid phase synthesis is the primary method of peptide production. However, it has drawbacks: large amount of chemical waste and rapid increase in price with peptide length. Bio
Externí odkaz:
https://doaj.org/article/827dc72a018e4fcbb4f558e7f1d216c2
Autor:
Thomas Lane, Vadim Makarov, Julie A. E. Nelson, Rick B. Meeker, Giuseppina Sanna, Olga Riabova, Elena Kazakova, Natalia Monakhova, Andrey Tsedilin, Fabio Urbina, Thane Jones, Ashley Suchy, Sean Ekins
Publikováno v:
Journal of Medicinal Chemistry. 66:6193-6217
Publikováno v:
Biotechnology reports (Amsterdam, Netherlands). 35
Synthetic peptides are in high demand as biologically active substances. Solid phase synthesis is the primary method of peptide production. However, it has drawbacks: large amount of chemical waste and rapid increase in price with peptide length. Bio
Autor:
Nikolskaya Elena B, Andrey Tsedilin, N. G. Yabbarov, Maria Sokol, Margarita Chirkina, Timofey Kuvaev, Artur Zabolotskii, M. D. Mollaev, Anna B. Pshenichnikova, Mariia Mollaeva, Neonila V. Gorokhovets
Publikováno v:
Journal of Genetic Engineering & Biotechnology
Journal of Genetic Engineering and Biotechnology, Vol 19, Iss 1, Pp 1-10 (2021)
Journal of Genetic Engineering and Biotechnology, Vol 19, Iss 1, Pp 1-10 (2021)
Background Difficult to express peptides are usually produced by co-expression with fusion partners. In this case, a significant mass part of the recombinant product falls on the subsequently removed fusion partner. On the other hand, multimerization